Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tycho Baumann

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
Leukemia & Lymphoma|October 1, 2016
T-cell subsets in lymph nodes identify a subgroup of follicular lymphoma patients with favorable outcomeLaura Magnano, Antonio Martínez, Joaquim Carreras, et al.
American Journal of Respiratory and Critical Care Medicine|July 11, 2009
Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trialChristian Meisel, Joerg C Schefold, Rene Pschowski, et al.
British Journal of Haematology|December 14, 2011
A new genetic abnormality leading to TP53 gene deletion in chronic lymphocytic leukaemiaCristina López, Tycho Baumann, Dolors Costa, et al.
Haematologica|June 29, 2014
Chronic lymphocytic leukemia in the elderly: clinico-biological features, outcomes, and proposal of a prognostic modelTycho Baumann, Julio Delgado, Rodrigo Santacruz, et al.
Annals of Hematology|February 25, 2021
Age and comorbidity are determining factors in the overall and relative survival of patients with follicular lymphomaPablo Mozas, Andrea Rivero, Alfredo Rivas-Delgado, et al.
Blood|November 19, 2020
IGLV3-21R110 identifies an aggressive biological subtype of chronic lymphocytic leukemia with intermediate epigeneticsFerran Nadeu, Romina Royo, Guillem Clot, et al.
Blood Cancer Journal|March 7, 2020
Patterns of change in treatment, response, and outcome in patients with follicular lymphoma over the last four decades: a single-center experiencePablo Mozas, Ferran Nadeu, Alfredo Rivas-Delgado, et al.
Leukemia Research|May 26, 2017
High serum levels of soluble interleukin-2 receptor (sIL2-R), interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF) are associated with adverse clinical features and predict poor outcome in diffuse large B-cell lymphomaIvan Dlouhy, Xavier Filella, Jordina Rovira, et al.
Blood|June 3, 2015
Mutations in CHD2 cause defective association with active chromatin in chronic lymphocytic leukemiaDavid Rodríguez, Gabriel Bretones, Víctor Quesada, et al.
Leukemia Research|May 31, 2020
High serum levels of IL-2R, IL-6, and TNF-α are associated with higher tumor burden and poorer outcome of follicular lymphoma patients in the rituximab eraPablo Mozas, Alfredo Rivas-Delgado, Andrea Rivero, et al.
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
Leukemia & Lymphoma|October 1, 2016
T-cell subsets in lymph nodes identify a subgroup of follicular lymphoma patients with favorable outcomeLaura Magnano, Antonio Martínez, Joaquim Carreras, et al.
American Journal of Respiratory and Critical Care Medicine|July 11, 2009
Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trialChristian Meisel, Joerg C Schefold, Rene Pschowski, et al.
British Journal of Haematology|December 14, 2011
A new genetic abnormality leading to TP53 gene deletion in chronic lymphocytic leukaemiaCristina López, Tycho Baumann, Dolors Costa, et al.
Haematologica|June 29, 2014
Chronic lymphocytic leukemia in the elderly: clinico-biological features, outcomes, and proposal of a prognostic modelTycho Baumann, Julio Delgado, Rodrigo Santacruz, et al.
Annals of Hematology|February 25, 2021
Age and comorbidity are determining factors in the overall and relative survival of patients with follicular lymphomaPablo Mozas, Andrea Rivero, Alfredo Rivas-Delgado, et al.
Blood|November 19, 2020
IGLV3-21R110 identifies an aggressive biological subtype of chronic lymphocytic leukemia with intermediate epigeneticsFerran Nadeu, Romina Royo, Guillem Clot, et al.
Blood Cancer Journal|March 7, 2020
Patterns of change in treatment, response, and outcome in patients with follicular lymphoma over the last four decades: a single-center experiencePablo Mozas, Ferran Nadeu, Alfredo Rivas-Delgado, et al.
Leukemia Research|May 26, 2017
High serum levels of soluble interleukin-2 receptor (sIL2-R), interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF) are associated with adverse clinical features and predict poor outcome in diffuse large B-cell lymphomaIvan Dlouhy, Xavier Filella, Jordina Rovira, et al.
Blood|June 3, 2015
Mutations in CHD2 cause defective association with active chromatin in chronic lymphocytic leukemiaDavid Rodríguez, Gabriel Bretones, Víctor Quesada, et al.
Leukemia Research|May 31, 2020
High serum levels of IL-2R, IL-6, and TNF-α are associated with higher tumor burden and poorer outcome of follicular lymphoma patients in the rituximab eraPablo Mozas, Alfredo Rivas-Delgado, Andrea Rivero, et al.
Pageof 6